Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans

Neurosci Lett. 2003 Dec 26;353(3):201-4. doi: 10.1016/j.neulet.2003.09.046.

Abstract

Apolipoprotein(a) [apo(a)] is a genetically polymorphic glycoprotein that has several similarities to apolipoprotein E. However, its role as a risk factor for frontotemporal dementia (FTD) remains to be elucidated. We therefore investigated the effect of an apo(a) polymorphism on the incidence of FTD in a sample of Caucasian Italian patients. From the entire group of FTD patients (n=54), 55.6% of the subjects had at least one apo(a) low molecular weight (MW) isoform, compared to 29.9% of non-demented controls (n=77). The difference between the two groups was statistically significant (odds ratio 2.93, 95% confidence interval 1.42-6.06, P=0.003). The FTD group was further divided into sporadic (n=26) and familial (n=28) cases. Even after such dichotomization, both sporadic and familial FTD patients showed a significantly higher prevalence of low MW apo(a) isoforms than the cognitively healthy controls (P=0.011 and P=0.025, respectively). Our data suggest a role of apo(a) phenotypes of low MW in mediating susceptibility to FTD.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Apolipoproteins A / blood*
  • Apolipoproteins A / metabolism
  • Case-Control Studies
  • Dementia / blood*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoblotting
  • Italy / epidemiology
  • Lipoprotein(a) / blood
  • Male
  • Middle Aged
  • Phenotype
  • Polymorphism, Genetic
  • Protein Isoforms / blood*
  • Protein Isoforms / metabolism
  • Random Allocation
  • Regression Analysis
  • Statistics, Nonparametric

Substances

  • Apolipoproteins A
  • Lipoprotein(a)
  • Protein Isoforms